Skip to main content
. 2024 Jan 2;30(1):117–129. doi: 10.1038/s41591-023-02659-z

Fig. 4. Inhibition of mosquito-bite parasitemia from mAbs prioritized for development.

Fig. 4

a, Hazard ratios of n = 25 antibodies (14 lineages) compared with AB-000317 in the mosquito-bite parasitemia model (n = 10 mice, 150 μg per mouse), with colors other than gray indicating the five lineages containing the most efficacious antibodies. b,c, Survival curves from repeat experiments in comparison with AB-000317 and AB-000224 (0.74 (0.15, 3.8)) (b) and AB-007088 (0.61 (0.097, 3.8)) (c); n = 10 mice, two-tailed, nonparametric log-rank (Mantel–Haenszel hazard ratio (95% CIs)).